Themis Medicare has received approval to transfer its Active Pharmaceutical ingredients (API) business including the manufacturing facilities of the Company at Vapi, Valsad District, Gujarat and Jeedimetla, Malkajgiri District, Telangana, to Themis Lifestyle -- a subsidiary of the Company on a going concern basis. The expected date of completion of the sale of the API business of the Company is by March 31, 2023 subject to receipt of all applicable approval. Cash consideration amounting to Rs 125 crore will be payable by the transferee company to the transferor company.
Themis Medicare is a research-based pharmaceutical company specializing in manufacture of a wide range of products for application areas like Pain Management, Critical Care and Anti-Infectives.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.55 |
| Dr. Reddys Lab | 1238.10 |
| Cipla | 1239.20 |
| Zydus Lifesciences | 942.70 |
| Lupin | 2325.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: